Volker Endris

7.5k citations

99 papers · 3.4k indexed · h-index 35

Impact in

Cancer Research top 1%
- Cancer Genomics and Diagnostics
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies

Papers in

Cancer Research 53
- Cancer Genomics and Diagnostics 50
Oncology 55
- Pancreatic and Hepatic Oncology Research 8
- Colorectal Cancer Treatments and Studies 8
- Lung Cancer Research Studies 8
- PARP inhibition in cancer therapy 7
- Cancer Immunotherapy and Biomarkers 7

Co-authors: Albrecht Stenzinger Peter Schirmacher Wilko Weichert Roland Penzel Nicole Pfarr Jan Budczies Anna‐Lena Volckmar Martina Kirchner
Journals: Genes Chromosomes and Cancer (16 papers)International Journal of Cancer (8 papers)Annals of Oncology (7 papers)Oncotarget (7 papers)Journal of Clinical Oncology (4 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Volker Endris

98 papers receiving 3.4k citations

Peers

Countries citing papers authored by Volker Endris

Since Specialization

Citations

This map shows the geographic impact of Volker Endris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Endris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Endris more than expected).

Fields of papers citing papers by Volker Endris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Endris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Endris. The network helps show where Volker Endris may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Volker Endris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Volker Endris Line = papers co-authored together Volker Endris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD) npj Precision Oncology ·Eugen Rempel, Klaus Kluck, Susanne Beck, Rose Ojuok, Daniel Kazdal, Olaf Neumann, Anna‐Lena Volckmar, Martina Kirchner, 刘新圣, Nicole Pfarr, Wilko Weichert, Daniel Hübschmann, Stefan Fröhling, Christian Sutter, Christian P. Schaaf, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Jan Budczies	2022	49
2	Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary Genes Chromosomes and Cancer ·Tilmann Bochtler, Trobina, Thomas Hielscher, Damian Stichel, Carl Brockelmann, BR Rajnikanth, Olaf Neumann, Volker Endris, Andreas von Deimling, Albrecht Stenzinger, Alwin Krämer	2022	5
3	Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of theNanoString nCountertechnology with targetedRNAsequencing Genes Chromosomes and Cancer ·Yujing Du, Eugen Rempel, Volker Endris, G.O. Okeng'o, Michael Allgäuer, Constantin Schwab, Daniel Kazdal, Fabian Stögbauer, Anna‐Lena Volckmar, Yutaka Satou, Olaf Neumann, Peter Schirmacher, Stefanie Zschäbitz, Stefan Duensing, Jan Budczies, Albrecht Stenzinger, Martina Kirchner	2020	9
4	Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary International Journal of Cancer ·Tilmann Bochtler, B HAN, Volker Endris, Thomas Hielscher, Anna‐Lena Volckmar, Olaf Neumann, Martina Kirchner, Jan Budczies, Lukas C. Heukamp, Jonas Leichsenring, Michael Allgäuer, Daniel Kazdal, H. Löffler, Wilko Weichert, Peter Schirmacher, Albrecht Stenzinger, Alwin Krämer	2020	10
5	The majority of β-catenin mutations in colorectal cancer is homozygous BMC Cancer ·Alexander Arnold, Hao Niu, Christine Sers, Aysel Ahadova, Volker Endris, Soulafa Mamlouk, David Horst, Markus Möbs, Philip Bischoff, Matthias Kloor, Hendrik Bläker	2020	28
6	Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome International Journal of Cancer ·Tilmann Bochtler, Volker Endris, Jonas Leichsenring, B HAN, Olaf Neumann, Anna‐Lena Volckmar, Martina Kirchner, Michael Allgäuer, Peter Schirmacher, Alwin Krämer, Albrecht Stenzinger	2019	20
7	Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer Molecular Case Studies ·Steffen Dietz, Petros Christopoulos, Lisa Gu, Anna‐Lena Volckmar, Volker Endris, Zhao Yuan, Alaina H. Campbell, Tomasz Żemojtel, Claus Peter Heußel, Marc A. Schneider, Michael Meister, Thomas Muley, Martin Reck, Matthias Schlesner, Michael Thomas, Albrecht Stenzinger, Holger Sültmann	2019	17
8	Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis International Journal of Cancer ·Ivo Buchhalter, Eugen Rempel, Volker Endris, Michael Allgäuer, Olaf Neumann, Anna‐Lena Volckmar, Martina Kirchner, Jonas Leichsenring, Amelie Lier, Moritz von Winterfeld, Roland Penzel, Petros Christopoulos, Michael Thomas, Stefan Fröhling, Peter Schirmacher, Jan Budczies, Albrecht Stenzinger	2018	117
9	Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas International Journal of Cancer ·Steffen Dietz, Aviezer Lifshitz, Daniel Kazdal, Alexander Harms, Volker Endris, H. Winter, Albrecht Stenzinger, Arne Warth, Martin Sill, Amos Tanay, Holger Sültmann	2018	24
10	Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study Genes Chromosomes and Cancer ·Anna‐Lena Volckmar, Volker Endris, Matthias M. Gaida, Jonas Leichsenring, Fabian Stögbauer, Michael Allgäuer, Moritz von Winterfeld, Roland Penzel, Martina Kirchner, Regine Brandt, Olaf Neumann, Holger Sültmann, Peter Schirmacher, Jochen Rudi, Daniel Schmitz, Albrecht Stenzinger	2018	14
11	EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK⁺ non‐small cell lung cancer International Journal of Cancer ·Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, P Buddenberg, Martina Kirchner, Jonas Ristau, Ivo Buchhalter, Roland Penzel, Felix Herth, Claus Peter Heußel, Martin Eichhorn, Thomas Muley, Michael Meister, Jürgen R. Fischer, Stefan Rieken, Arne Warth, Helge Bischoff, Peter Schirmacher, Albrecht Stenzinger, Michael Thomas	2018	79
12	Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility Genes Chromosomes and Cancer ·Jonas Leichsenring, Anna‐Lena Volckmar, Martina Kirchner, Daniel Kazdal, Mark Kriegsmann, Fabian Stögbauer, Osamu Sakata, Frederick Klauschen, Felix Herth, Roland Penzel, Arne Warth, Peter Schirmacher, Volker Endris, Albrecht Stenzinger	2017	13
13	Mutational profiles of Brenner tumors show distinctive features uncoupling urothelial carcinomas and ovarian carcinoma with transitional cell histology Genes Chromosomes and Cancer ·Nicole Pfarr, Silvia Darb‐Esfahani, Jonas Leichsenring, Eliane T. Taube, Melanie Boxberg, Elena Ioana Braicu, Moritz Jesinghaus, Roland Penzel, Volker Endris, Aurelia Noske, Wilko Weichert, Peter Schirmacher, Carsten Denkert, Albrecht Stenzinger	2017	16
14	Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan‐cancer survey with implications for the use of immune checkpoint inhibitors Genes Chromosomes and Cancer ·Jan Budczies, Michael Bockmayr, Frederick Klauschen, Volker Endris, Stefan Fröhling, Peter Schirmacher, Carsten Denkert, Albrecht Stenzinger	2017	32
15	A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications Genes Chromosomes and Cancer ·Anna‐Lena Volckmar, Holger Sültmann, Anja Lisa Riediger, Thoas Fioretos, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Steffen Dietz	2017	146
16	Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance Genes Chromosomes and Cancer ·Nicole Pfarr, Roland Penzel, Volker Endris, 一徳五十嵐, Christa Flechtenmacher, Anna‐Lena Volckmar, Martina Kirchner, Jan Budczies, Jonas Leichsenring, Esther Herpel, Aurelia Noske, Wilko Weichert, Andreas Schneeweiß, Peter Schirmacher, Hans‐Peter Sinn, Albrecht Stenzinger	2016	16
17	Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia Molecular Case Studies ·Tilmann Bochtler, Stefan Fröhling, Wilko Weichert, Volker Endris, Christian Thiede, Barbara Hutter, Michael Hundemer, Anthony D. Ho, Alwin Krämer	2016	2
18	Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissue International Journal of Molecular Medicine ·Jana Fassunke, Florian Haller, Marta Rodríguez Mazón, Evgeny A. Moskalev, Roland Penzel, Nicole Pfarr, Sabine Merkelbach‐Bruse, Volker Endris	2015	11
19	Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer Journal of Clinical Pathology ·Jan Budczies, Moritz von Winterfeld, Frederick Klauschen, Francine Maciello, Jan‐Marcus Daniel, Arne Warth, Volker Endris, Carsten Denkert, Heriberto Pfeiffer, Wilko Weichert, Manfred Dietel, Daniel Wittschieber, Albrecht Stenzinger	2014	13
20	MEGAP impedes cell migration via regulating actin and microtubule dynamics and focal complex formation Experimental Cell Research ·Ying Yang, Marco Marcello, Volker Endris, Rainer Saffrich, Roger Fischer, Michael F. Trendelenburg, Rolf Sprengel, Gudrun Rappold	2006	46

About Volker Endris

Volker Endris is a scholar working on Cancer Research, Oncology, Microbiology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (50 papers), Lung Cancer Treatments and Mutations (26 papers), Genetic factors in colorectal cancer (15 papers), Pancreatic and Hepatic Oncology Research (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Lung Cancer Research Studies (8 papers), PARP inhibition in cancer therapy (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.7k citations), Pathology and Forensic Medicine (676 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Molecular Biology (1.2k citations). Volker Endris has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Albrecht Stenzinger, Peter Schirmacher, Wilko Weichert, Roland Penzel, Nicole Pfarr, Jan Budczies, Anna‐Lena Volckmar, Martina Kirchner, Gudrun Rappold and Arne Warth. Their work appears in journals such as Genes Chromosomes and Cancer, International Journal of Cancer, Annals of Oncology, Oncotarget and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact